Search for: "WYETH HOLDINGS CORPORATION" Results 21 - 40 of 112
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Mar 2009, 8:26 am
Duff & Phelps, now an anchor tenant in the corporate law canon.) [read post]
21 Nov 2010, 5:56 pm by Steve McConnell
Nor are we talking about civil plaintiffs who genuinely seek to hold corporate employees liable. [read post]
3 Jun 2008, 3:05 am
  Over a decade later, these lower-cost provisional filings have taken hold. [read post]
29 Nov 2010, 6:48 pm by Kelly
Companies like Apple, Microsoft, Pfizer, Dell and Wyeth have flocked to the Emerald Isle to avoid paying higher tax rates elsewhere. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
  Wyeth would both forgo marketing its own authorized generic during that period and allow Wyeth’s generic Effexor to come to market early” (emphasis in original). [read post]
31 Dec 2009, 7:19 am
’s proposed $68 billion acquisition of Wyeth, and Schering-Plough Corporation was permitted to proceed with its proposed $41.1 billion acquisition of Merck & Co. [read post]
12 Mar 2024, 12:46 pm by admin
Wyeth-Ayerst Laboratories Co., 278 F.Supp.2d 684, 700 (W.D.N.C. 2003) (expert witnesses may not opine about corporate intent and motive) (barring Dr. [read post]
13 Nov 2009, 7:35 am by Don Cruse
The Wall Street Journal opined that "the aftermath of Kelo is the latest example of the futility of using eminent domain as corporate welfare. [read post]
10 Jun 2014, 10:11 am by Robert Percival
   Justice Kennedy has been the decisive vote not only in Wyeth, but also in two subsequent five-to-four decisions holding that such lawsuits are preempted when brought against manufacturers of chemically identical generic drugs, a result that even Justices who supported this outcome agree “makes little sense. [read post]
8 Dec 2016, 2:48 pm by Ben Vernia
 Wyeth was required to disclose these discounts so the government could make sure its Medicaid program enjoyed the same pricing benefits Wyeth made available to its commercial customers. [read post]
31 Jul 2018, 2:29 pm by Sarah Aberg and Bochan Kim
Martoma’s portfolio included two pharmaceutical companies, Elan Corporation, plc (“Elan”) and Wyeth Pharmaceuticals, Inc. [read post]